China Pharma Holdings (CPHI) Current Assets (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Current Assets came in at $2.0 million in Q1 2026, down 29.72% YoY from $2.9 million in Q1 2025, and down 14.61% on a QoQ basis from $2.3 million in Q4 2025.
China Pharma Holdings (CPHI) Current Assets (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Current Assets data on file, last reported at $2.0 million in Q1 2026.
- Quarterly Current Assets fell 29.72% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 29.72% YoY) and the FY2025 annual result came in at $2.3 million, down 28.25% from the prior year.
- Current Assets declined to $2.0 million in Q1 2026, from $2.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $8.2 million in Q1 2022 to a low of $2.0 million in Q1 2026.
- A 5-year average of $4.6 million and a median of $5.1 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets jumped 67.22% — and 2024, when it plunged 45.47%.
- Tracing CPHI's Current Assets over 5 years: stood at $6.0 million in 2022, then grew by 0.54% to $6.0 million in 2023, then plunged by 45.47% to $3.3 million in 2024, then retreated by 28.25% to $2.3 million in 2025, then slipped by 14.61% to $2.0 million in 2026.
- The last three Current Assets figures came in at $2.0 million (Q1 2026), $2.3 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | 2.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 2.35 Mn |
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Dec 31, 2024 | 3.27 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | 3.97 Mn |
| Mar 31, 2024 | 5.12 Mn |
| Dec 31, 2023 | 6.00 Mn |
| Sep 30, 2023 | 5.81 Mn |
| Jun 30, 2023 | 5.53 Mn |
| Mar 31, 2023 | 6.08 Mn |
| Dec 31, 2022 | 5.96 Mn |
| Sep 30, 2022 | 5.61 Mn |
| Jun 30, 2022 | 6.26 Mn |
| Mar 31, 2022 | 8.17 Mn |
| Dec 31, 2021 | 9.09 Mn |
| Sep 30, 2021 | 4.14 Mn |
| Jun 30, 2021 | 5.26 Mn |